Nalcrom (sodium cromoglicate)

“Sodium cromoglycate is considered to exert a stabilizing effect upon mast cells capable of releasing mediators. In gastrointestinal disease the release of mediators causes a local inflammation which can either result in gastrointestinal symptoms or may allow absorption of
antigenic material leading to systemic allergic reactions. Sodium cromoglycate has no antihistaminic or anti-inflammatory activity.”
http://products.sanofi.ca/en/nalcrom.pdf

Updates

Nalcrom capsules update as of 17 May 2021:

Nalcrom is expected back with UK distributors in the week commencing 24 May, 2021.  It will be distributed only by Phoenix and AAH, who supply to pharmacies.  As these may not the usual distributors your pharmacy uses, you may need to direct your pharmacist to try these distributors.

 

Intal inhaler update  as of 17 May 2021:

Intal inhalers should be available via Phoenix and AAH, distributors who supply to pharmacies.  They became available as of the week commencing 10 May, 2021. As these may not the usual distributors your pharmacy uses, you may need to direct your pharmacist to try these distributors.

 

Nalcrom Update as of 16 March 2021